Use of letermovir‐valganciclovir combination as a step‐down treatment after foscarnet for ganciclovir‐resistant CMV infection in kidney transplant recipients-Reference-Cited by-同舟云学术

Use of letermovir‐valganciclovir combination as a step‐down treatment after foscarnet for ganciclovir‐resistant CMV infection in kidney transplant recipients

Published:2021-10-28 Issue:11 Volume:35 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Rho Elena¹^ORCID,Näf Bettina²,Müller Thomas F²,Wüthrich Rudolf P²^ORCID,Schachter Thomas²^ORCID,Moos Seraina²^ORCID

Affiliation:

1. Division of Internal Medicine Cantonal Hospital of Winterthur Winterthur Switzerland

2. Division of Nephrology University Hospital Zurich Zurich Switzerland

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14401

Reference26 articles.

1. Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

2. Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

3. Cytomegalovirus-specific T-cell immunity to assign the infection status in individuals with passive immunity: A proof of principle

4. CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor

5. CMV Prevention and Treatment in Transplantation: What’s New in 2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A broadly neutralizing human monoclonal antibody generated from transgenic mice immunized with HCMV particles limits virus infection and proliferation;Journal of Virology;2024-07-23

2. Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighting the Role of Advanced Practice Providers (Nurse Practitioners and Physician Assistants);Annals of Transplantation;2024-03-15

3. Antiviral Agents: Letermovir;Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century;2024

4. Letermovir Rescue Therapy in Kidney Transplant Recipients with Refractory/Resistant CMV Disease;Journal of Clinical Medicine;2023-12-23

5. What’s New: Updates on Cytomegalovirus in Solid Organ Transplantation;Transplantation;2023-10-30